Scott M. Matson

970 total citations
20 papers, 165 citations indexed

About

Scott M. Matson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Scott M. Matson has authored 20 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Scott M. Matson's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Systemic Sclerosis and Related Diseases (7 papers). Scott M. Matson is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Systemic Sclerosis and Related Diseases (7 papers). Scott M. Matson collaborates with scholars based in United States, United Kingdom and Japan. Scott M. Matson's co-authors include Joyce Lee, M. Kristen Demoruelle, Oliver Eickelberg, David S. McKenna, Mario Castro, Misbah Baqir, Christopher M. Walker, Francisco J. Díaz, Teng Moua and Junqiang Dai and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Thorax.

In The Last Decade

Scott M. Matson

15 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott M. Matson United States 5 106 59 59 38 33 20 165
Fabián Caro Argentina 9 142 1.3× 18 0.3× 65 1.1× 36 0.9× 19 0.6× 21 155
José Antonio Rodríguez Portal Spain 7 121 1.1× 26 0.4× 53 0.9× 22 0.6× 9 0.3× 18 138
Miguel García González Spain 6 53 0.5× 20 0.3× 21 0.4× 18 0.5× 35 1.1× 20 160
Danai Βisirtzoglou Greece 3 407 3.8× 34 0.6× 150 2.5× 32 0.8× 40 1.2× 3 417
Sérgio Jezler Brazil 7 62 0.6× 11 0.2× 12 0.2× 14 0.4× 12 0.4× 11 112
Lykourgos Kolilekas Greece 6 94 0.9× 19 0.3× 65 1.1× 6 0.2× 10 0.3× 17 171
Susanne Webster Australia 8 165 1.6× 31 0.5× 61 1.0× 5 0.1× 16 0.5× 13 180
Divya Patel United States 7 128 1.2× 25 0.4× 86 1.5× 6 0.2× 24 0.7× 53 183
Taryn Reddy Australia 5 314 3.0× 24 0.4× 114 1.9× 10 0.3× 74 2.2× 8 321
S Field United States 2 199 1.9× 48 0.8× 226 3.8× 18 0.5× 24 0.7× 2 252

Countries citing papers authored by Scott M. Matson

Since Specialization
Citations

This map shows the geographic impact of Scott M. Matson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Matson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Matson more than expected).

Fields of papers citing papers by Scott M. Matson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Matson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Matson. The network helps show where Scott M. Matson may publish in the future.

Co-authorship network of co-authors of Scott M. Matson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott M. Matson. A scholar is included among the top collaborators of Scott M. Matson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott M. Matson. Scott M. Matson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
England, Bryant R., Joshua F. Baker, Michael George, et al.. (2025). Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study. The Lancet Rheumatology. 7(3). e166–e177. 4 indexed citations
2.
Wichman, Christopher, Jianghu Dong, Punyasha Roul, et al.. (2025). Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study. Seminars in Arthritis and Rheumatism. 73. 152735–152735. 3 indexed citations
3.
Mudaranthakam, Dinesh Pal, Susan Mathai, Ayodeji Adegunsoye, et al.. (2025). Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease. PubMed. 3(2). 100159–100159.
4.
Johnson, Tate, Yangyuna Yang, Punyasha Roul, et al.. (2025). Peripheral Biomarker Signatures in Rheumatoid Arthritis–Associated Interstitial Lung Disease. Arthritis & Rheumatology. 77(8). 971–980. 2 indexed citations
5.
6.
Matson, Scott M., Jiwoong Choi, Tae‐Won Kim, et al.. (2024). Airways Abnormalities in a Prospective Cohort of Patients With Rheumatoid Arthritis. CHEST Journal. 167(2). 495–506. 1 indexed citations
7.
Harrison, A. Marc, et al.. (2024). Spectrum of Pulmonary Manifestations in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis on Chest CT. American Journal of Roentgenology. 224(2). e2431477–e2431477. 1 indexed citations
8.
Koestler, Devin C., Atsushi Saitô, A. Marc Harrison, et al.. (2024). Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung disease. ERJ Open Research. 10(6). 192–2024. 2 indexed citations
9.
Thiele, Geoffrey M., Michael J. Duryee, Carlos D. Hunter, et al.. (2024). Antibodies to Malondialdehyde‐Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis–Associated Interstitial Lung Disease in US Veterans. Arthritis & Rheumatology. 76(9). 1353–1363. 2 indexed citations
10.
Matson, Scott M. & M. Kristen Demoruelle. (2024). Connective Tissue Disease Associated Interstitial Lung Disease. Rheumatic Disease Clinics of North America. 50(3). 423–438. 4 indexed citations
11.
Matson, Scott M. & Joyce Lee. (2024). An overview of screening, treatment, and next steps in research in rheumatoid arthritis interstitial lung disease. Revista Colombiana de Reumatología (English Edition). 31. S26–S34.
12.
Matson, Scott M. & Joyce Lee. (2023). An overview of screening, treatment, and next steps in research in rheumatoid arthritis interstitial lung disease. Revista Colombiana de Reumatología. 31. S26–S34.
13.
Matson, Scott M. & M. Kristen Demoruelle. (2023). Connective Tissue Disease Associated Interstitial Lung Disease. Immunology and Allergy Clinics of North America. 43(2). 229–244. 3 indexed citations
14.
Matson, Scott M., et al.. (2023). PULMONARY ALVEOLAR PROTEINOSIS SECONDARY TO EVEROLIMUS. CHEST Journal. 164(4). A3169–A3170.
15.
Matson, Scott M., Misbah Baqir, Teng Moua, et al.. (2022). Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease. CHEST Journal. 163(4). 861–869. 43 indexed citations
16.
Matson, Scott M., M. Kristen Demoruelle, & Mario Castro. (2021). Airway Disease in Rheumatoid Arthritis. Annals of the American Thoracic Society. 19(3). 343–352. 22 indexed citations
17.
Matson, Scott M., Joyce Lee, & Oliver Eickelberg. (2020). Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease. European Respiratory Journal. 57(5). 2002533–2002533. 39 indexed citations
18.
19.
McKenna, David S., et al.. (2003). Maternal Group B Streptococcal (GBS) Genital TractColonization at Term in Women who Have AsymptomaticGBS Bacteriuria. Infectious Diseases in Obstetrics and Gynecology. 11(4). 203–207. 37 indexed citations
20.
Anderson, D. M. & Scott M. Matson. (1999). Pancreatic cystic neoplasms. The Journal of the American Osteopathic Association. 99(5). 270–274. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabián Caro Breakdown of academic impact, for papers by José Antonio Rodríguez Portal Breakdown of academic impact, for papers by Miguel García González Breakdown of academic impact, for papers by Danai Βisirtzoglou Breakdown of academic impact, for papers by Sérgio Jezler Breakdown of academic impact, for papers by Lykourgos Kolilekas Breakdown of academic impact, for papers by Susanne Webster Breakdown of academic impact, for papers by Divya Patel Breakdown of academic impact, for papers by Taryn Reddy Breakdown of academic impact, for papers by S Field
Rankless by CCL
2026